Refine
Year of publication
Document Type
- Article (381)
- Preprint (250)
- Working Paper (4)
- Part of Periodical (2)
- Conference Proceeding (1)
- Contribution to a Periodical (1)
Has Fulltext
- yes (639)
Is part of the Bibliography
- no (639)
Keywords
- BESIII (19)
- e +-e − Experiments (16)
- Branching fraction (12)
- Particle and Resonance Production (8)
- Quarkonium (7)
- Charm Physics (6)
- Spectroscopy (6)
- Hadronic decays (5)
- Branching fractions (4)
- Charmonium (4)
- Exotics (4)
- Heavy-ion collisions (4)
- Lepton colliders (4)
- SARS-CoV-2 (4)
- COVID19-NMR (3)
- Charmed mesons (3)
- Deutschland (3)
- Diffraction (3)
- Elastic scattering (3)
- Electroweak interaction (3)
- Genetics (3)
- Initial state radiation (3)
- Polarization (3)
- QCD (3)
- e+-e− Experiments (3)
- Absolute branching fraction (2)
- Beam Energy Scan (2)
- Bhabha (2)
- COVID-19 (2)
- Charm physics (2)
- Chiral Magnetic Effect (2)
- Collectivity (2)
- Correlation (2)
- Cross section (2)
- Electroweak Interaction (2)
- Everolimus (2)
- Flavour Physics (2)
- Hadronic cross section (2)
- Kidney transplantation (2)
- Leptonic, semileptonic & radiative decays (2)
- Marktanteil (2)
- Molecular biology (2)
- Muon anomaly (2)
- NMR (2)
- Particle decays (2)
- Pion form factor (2)
- RHIC (2)
- Radiative decay (2)
- STAR (2)
- Shear viscosity (2)
- Solution NMR spectroscopy (2)
- decays (2)
- pest risk mapping (2)
- risk factors (2)
- 5'-UTR (1)
- 5_SL4 (1)
- 5′-UTR (1)
- 889 vs R. pygmaea (Brauer, 1867) (1)
- ACLF (1)
- ALK-rearranged NSCLC (1)
- ARDS (1)
- Absatzweg (1)
- Abwanderung-Widerspruch-Theorie (1)
- Advanced biliary tract cancer (1)
- Age estimation (1)
- American crocodile (1)
- Angular distribution (1)
- Annihilation (1)
- Antibody-mediated rejection (1)
- Archibasis (1)
- Atmospheric chemistry (1)
- B-slope (1)
- BESIII detector (1)
- BTC (1)
- Bacterial Protein Kinases (1)
- Bacterial Protein Phosphatases (1)
- Barcoding (1)
- Beam energy scan (1)
- Biogeography (1)
- Biological profile (1)
- Biopsy (1)
- Bipolar disorder (1)
- Born cross section (1)
- Born cross section measurement (1)
- Brain tumor (1)
- Branching fraction measurement (1)
- Burden of disease (1)
- CAKUT (1)
- CP violation (1)
- CRM (1)
- CVD biomarker (1)
- Cardiac implantable electronic devices (1)
- Cardiac rehabilitation (1)
- Cardiac resynchronization therapy (1)
- Cardiovascular disease (1)
- Carnivores (1)
- Cdk1/cyclin B1 (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Charm vector (1)
- Charmed baryon (1)
- Charmonia (1)
- Charmonium (-like) (1)
- Child abuse (1)
- Chiral magnetic effect (1)
- Circadian (1)
- Cirrhosis (1)
- Climate-change impacts (1)
- Coalescence (1)
- Cold nuclear matter effects (1)
- Colorectal cancer (1)
- Consensus document (1)
- Costa Rica (1)
- Covariance matrix (1)
- Credit union (1)
- Critical care (1)
- Critical point (1)
- Crocodylus acutus (1)
- Cross section measurements (1)
- Cryptic species (1)
- D meson (1)
- D0 and D+ mesons (1)
- DIPSHIFT (1)
- DNA barcodingbased identification (1)
- Dalitz decay (1)
- Dark photon (1)
- Dark sector (1)
- Data sharing (1)
- Density equalizing mapping (1)
- Deuteron production (1)
- Devic disease (1)
- Devic syndrome (1)
- Di-hadron correlations (1)
- Diabetes (1)
- Diabetes mellitus (1)
- Digital (1)
- Divergence time estimate (1)
- Drug Resistance (1)
- D⁰ meson (1)
- EWSR1 (1)
- Ecology (1)
- Ecophysiology (1)
- Effective form factor (1)
- Electromagnetic amplitude (1)
- Electromagnetic form factor (1)
- Electromagnetic form factors (1)
- Elliptic flow (1)
- Entomology (1)
- Equity (1)
- Exercise training (1)
- Experimental nuclear physics (1)
- Experimental particle physics (1)
- FOS: Physical sciences (1)
- Flavor changing neutral currents (1)
- Flavor symmetries (1)
- Flow (1)
- Fonds (1)
- Forensic examination (1)
- Forensic pathology (1)
- Form factors (1)
- Forward physics (1)
- G protein-coupled receptors (1)
- Gene fusion (1)
- Generalist (1)
- German Corporate Governance System (1)
- Geschichte 1986-1998 (1)
- Glomerulosclerosis (1)
- Groomed jet radius (1)
- HCC (1)
- Hadron-Hadron scattering (experiments) (1)
- Hadronization (1)
- Hadrons (1)
- Hand-foot syndrome (1)
- Health care resource utilization (1)
- Heart failure (1)
- Heavy Ion Experiments (1)
- Heavy Quark Production (1)
- Heavy ion collisions (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-ion (1)
- Helicity amplitude analysis (1)
- Hif1α (1)
- High Energy Physics - Experiment (hep-ex) (1)
- Higher moments (1)
- Human-mediated dispersal (1)
- Hyperons (1)
- Immunogenetics (1)
- Immunology (1)
- Implantable cardioverter-defibrillator (1)
- Inclusive branching fraction (1)
- Interference fragmentation function (1)
- Intimal-medial thickness (1)
- Investmentfonds (1)
- Invisible decays (1)
- J/ψ suppression (1)
- Jet substructure (1)
- K0S (1)
- K48-linked (1)
- K63-linked (1)
- Kreditgenossenschaft (1)
- Kreditgenossenschaftlicher Verbund (1)
- Lifestyle (1)
- Limón (1)
- Low Molecular Weight PTP (1)
- MN1 (1)
- MS (1)
- Macrodomain (1)
- Macromia (1)
- Mergers and Acquisitions (1)
- Metabolic syndrome (1)
- Mitgliedschaft (1)
- Mongolian spot (1)
- MptpA (1)
- Multiple parton interactions (1)
- Mycobacterium tuberculosis (1)
- NAFLD (1)
- NASH (1)
- NMO-IgG (1)
- NMR spectroscopy (1)
- Net-charge correlations (1)
- Net-charge fluctuations (1)
- Neuroepithelial (1)
- Neuromyelitis optica (1)
- Neurooncology (1)
- Neutrinos (1)
- Nevus of Ito (1)
- Nevus of Ota (1)
- Non-structural protein (1)
- Nonflow (1)
- Obesity (1)
- Oncogenes (1)
- Outcome (1)
- PATZ1 (1)
- PDGFRβ (1)
- PTDM (1)
- Pacemaker (1)
- Particle and resonance production (1)
- Particle phenomena (1)
- Patient safety (1)
- Pediatric (1)
- Phase (1)
- Phyllothemis raymondi (1)
- Phylogenomics (1)
- Phylogeny (1)
- Phylogeography (1)
- Physical activity (1)
- Population genetics (1)
- Post-transplant (1)
- Poverty (1)
- Prevention (1)
- Prognostic models (1)
- Protein drugability (1)
- Proton (1)
- Proton-proton collisions (1)
- Proton–proton collisions (1)
- Psychiatric disorders (1)
- Psychiatry (1)
- PtkA (1)
- Quantum chromodynamics (1)
- R value (1)
- RNA genome (1)
- Raiffeisenbank (1)
- Randomized (1)
- Rare decays (1)
- Research architecture (1)
- Risk aversion (1)
- SL1 (1)
- SLC20A1 (1)
- SPSS (1)
- Schätzung (1)
- Sclerotic glomeruli (1)
- Seasonal variation (1)
- Semi-leptonic decays (1)
- Social determinants (1)
- SoftDrop (1)
- Solar insolation (1)
- Solution NMR-spectroscopy (1)
- Sorafenib (1)
- Spin alignment (1)
- Spine care (1)
- Splitting function (1)
- Standardization (1)
- Strong amplitude (1)
- Suicide (1)
- Sunlight (1)
- TOR inhibitor (1)
- TP53 mutation status (1)
- Techniques Electromagnetic calorimeters (1)
- Thermal model (1)
- Threshold effect (1)
- Transversity (1)
- Triple quarkonia (1)
- USA (1)
- V. sotoarenasii (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- Vanilla planifolia (1)
- Vitamin D (1)
- Volksbank (1)
- Vulpes (1)
- W-exchange (1)
- Wachstum (1)
- Y (4260) (1)
- Y states (1)
- abnormal returns (1)
- accessory proteins (1)
- acute decompensation (1)
- acute-on-chronic liver failure (1)
- adaptive cardiac remodelling (1)
- adverse effects (1)
- aged (1)
- aging (1)
- alternative oxidase (1)
- aquaporin-4 (AQP4) antibody (1)
- bladder exstrophy-epispadias complex (1)
- branching fractions (1)
- c-kit (1)
- cancer (1)
- cardiac ischaemia‐reperfusion (1)
- cardiac magnetic (1)
- cardiomyopathy (1)
- cell stress (1)
- cell-free expression (1)
- cell-free protein synthesis (1)
- center-of-mass energy (1)
- cerebrospinal fluid (1)
- charmed baryon (1)
- charmonium-like states (1)
- chromosome segregation (1)
- cirrhosis (1)
- clinical features (1)
- cloacal malformation (1)
- common bond (1)
- complications (1)
- computed tomography (1)
- consensus (1)
- decay (1)
- decision-making under uncertainty (1)
- dimuon (1)
- diphoton (1)
- distribution channel (1)
- dynamics (1)
- e+e − annihilation (1)
- e+e⁻ − Experiments (1)
- e+e− Experiments (1)
- e+e− annihilation (1)
- ectosomes (1)
- electron transport chain (1)
- electron-positron collision (1)
- epidemiology (1)
- exosomes (1)
- extracellular vesicles (1)
- firewood (1)
- firewood movement (1)
- forest pests (1)
- functional genetics (1)
- fund growth (1)
- global change (1)
- guidelines (1)
- habitat destruction (1)
- hadron spectroscopy (1)
- hadronic events (1)
- heavy-ion collisions (1)
- helicity amplitude analysis (1)
- hepatic encephalopathy (1)
- inclusive J/ψ decays (1)
- inflammation (1)
- intrinsically disordered region (1)
- investment decisions (1)
- kidney formation (1)
- land use (1)
- left ventricular non-compaction (1)
- left ventricular trabeculation (1)
- liver (1)
- longitudinally extensive transverse myelitis (1)
- luminosity (1)
- mTOR inhibitor (1)
- magic angle spinning (1)
- magnetic resonance imaging (1)
- market shares (1)
- metabolic syndromes (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- mitosis (1)
- mortality (1)
- mouse (1)
- mtDNA (1)
- mtDNA control region (1)
- mutual fund performance (1)
- mutual funds (1)
- network modelling (1)
- neurodegeneration (1)
- nonstructural proteins (1)
- number of J/ψ events (1)
- osteoporosis (1)
- p+p collisions (1)
- p21 phosphorylation (1)
- p21 stability (1)
- participation rate (1)
- pathway invasion model (1)
- pedicle screws (1)
- peri-implantitis (1)
- polyubiquitin (1)
- portal hypertension (1)
- portosystemic shunt (1)
- radiation (1)
- reactive oxygen species (1)
- recurrent optic neuritis (1)
- reproducibility (1)
- resonance (1)
- rigor (1)
- risk factor progression (1)
- screw augmentation (1)
- screw loosening (1)
- semi-parametric estimation (1)
- sequential ALK-inhibitor therapy (1)
- simulation (1)
- spinal fusion (1)
- spontaneous portosystemic shunt (1)
- standardization (1)
- stochastic dominance (1)
- stroke (1)
- structural proteins (1)
- taxonomic status of Rhyothemis fulgens Kirby (1)
- tetraquark (1)
- thrombolysis (1)
- training (1)
- trigger efficiency (1)
- ubiquitin-conjugating enzymes (1)
- uncertainty (1)
- urinary tract development (1)
- zebrafish development (1)
- Λ+c baryon (1)
- Λc⁺ (1)
- Σ hyperon (1)
- Υ suppression (1)
- ψ(3686) (1)
Institute
Accurate measurement of the standard 235U(n,f) cross section from thermal to 170 keV neutron energy
(2020)
An accurate measurement of the 235U(n,f) cross section from thermal to 170 keV of neutron energy has recently been performed at n_TOF facility at CERN using 6Li(n,t)4He and 10B(n,α)7Li as references. This measurement has been carried out in order to investigate a possible overestimation of the 235U fission cross section evaluation provided by most recent libraries between 10 and 30 keV. A custom experimental apparatus based on in-beam silicon detectors has been used, and a Monte Carlo simulation in GEANT4 has been employed to characterize the setup and calculate detectors efficiency. The results evidenced the presence of an overestimation in the interval between 9 and 18 keV and the new data may be used to decrease the uncertainty of 235U(n,f) cross section in the keV region.
233U is the fissile nuclei in the Th-U fuel cycle with a particularily small neutron capture cross setion which is on average about one order of magnitude lower than its fission cross section. Hence, the measurement of the 233U(n, γ) cross section relies on a method to accurately distinguish between capture and fission γ-rays. A measurement of the 233U α-ratio has been performed at the n_TOF facility at CERN using a so-called fission tagging setup, coupling n_TOF 's Total Absorption Calorimeter with a novel fission chamber to tag the fission γ-rays. The experimental setup is described and essential parts of the analysis are discussed. Finally, a preliminary 233U α-ratio is presented.
233U is of key importance among the fissile nuclei in the Th-U fuel cycle. A particularity of 233U is its small neutron capture cross-section, which is on average about one order of magnitude lower than the fission cross-section. The accuracy in the measurement of the 233U capture cross-section depends crucially on an efficient capture-fission discrimination, thus a combined set-up of fission and γ-detectors is needed. A measurement of the 233U capture cross-section and capture-to-fission ratio was performed at the CERN n_TOF facility. The Total Absorption Calorimeter (TAC) of n_TOF was employed as γ-detector coupled with a novel compact ionization chamber as fission detector. A brief description of the experimental set-up will be given, and essential parts of the analysis procedure as well as the preliminary response of the set-up to capture are presented and discussed.
New neutron cross section measurements of minor actinides have been performed recently in order to reduce the uncertainties in the evaluated data, which is important for the design of advanced nuclear reactors and, in particular, for determining their performance in the transmutation of nuclear waste. We have measured the 241Am(n,γ) cross section at the n_TOF facility between 0.2 eV and 10 keV with a BaF2 Total Absorption Calorimeter, and the analysis of the measurement has been recently concluded. Our results are in reasonable agreement below 20 eV with the ones published by C. Lampoudis et al. in 2013, who reported a 22% larger capture cross section up to 110 eV compared to experimental and evaluated data published before. Our results also indicate that the 241Am(n,γ) cross section is underestimated in the present evaluated libraries between 20 eV and 2 keV by 25%, on average, and up to 35% for certain evaluations and energy ranges.
Neutron-induced fission cross sections of isotopes involved in the nuclear fuel cycle are vital for the design and safe operation of advanced nuclear systems. Such experimental data can also provide additional constraints for the adjustment of nuclear model parameters used in the evaluation process, resulting in the further development of fission models. In the present work, the 237Np(n,f) cross section was studied at the EAR2 vertical beam-line at CERN's n_TOF facility, over a wide range of neutron energies, from meV to MeV, using the time-of-flight technique and a set-up based on Micromegas detectors, in an attempt to provide accurate experimental data. Preliminary results in the 200 keV – 14 MeV neutron energy range as well as the experimental procedure, including a description of the facility and the data handling and analysis, will be presented.
We have measured the γ-rays following neutron capture on 240Pu and 244 Cm at the n_TOF facility at CERN with the Total Absorption Calorimeter (TAC) and with C6D6 organic scintillators. The TAC is made of 40 BaF2 crystals operating in coincidence and covering almost the entire solid angle. This allows to obtain information concerning the energy spectra and the multiplicity of the measured capture γ-ray cascades. Additional information is also obtained from the C6D6 detectors. We have analyzed the measured data in order to draw conclusions about the Photon Strength Functions (PSFs) of 241Pu and 245Cm below their neutron separation energies. The analysis has been performed by fitting the PSFs to the experimental results, using the differential evolution method, in order to find neutron capture cascades capable of reproducing at the same time a great variety of deposited energy spectra.
The design and operation of innovative nuclear systems requires a better knowledge of the capture and fission cross sections of the Pu isotopes. For the case of capture on 242Pu, a reduction of the uncertainty in the fast region down to 8-12% is required. Moreover, aiming at improving the evaluation of the fast energy range in terms of average parameters, the OECD NEA High Priority Request List (HPRL) requests high-resolution capture measurements with improved accuracy below 2 keV. The current uncertainties also affect the thermal point, where previous experiments deviate from each other by 20%. A fruitful collaboration betwen JGU Mainz and HZ Dresden-Rossendorf within the EC CHANDA project resulted in a 242Pu sample consisting of a stack of seven fission-like targets making a total of 95(4) mg of 242Pu electrodeposited on thin (11.5 μm) aluminum backings. This contribution presents the results of a set of measurements of the 242Pu(n, γ) cross section from thermal to 500 keV combining different neutron beams and techniques. The thermal point was determined at the Budapest Research Reactor by means of Neutron Activation Analysis and Prompt Gamma Analysis, and the resolved (1 eV - 4 keV) and unresolved (1 - 500 keV) resonance regions were measured using a set of four Total Energy detectors at the CERN n_TOF-EAR1.
The accuracy on neutron capture cross section of fissile isotopes must be improved for the design of future nuclear systems such as Gen-IV reactors and Accelerator Driven Systems. The High Priority Request List of the Nuclear Energy Agency, which lists the most important nuclear data requirements, includes also the neutron capture cross sections of fissile isotopes such as 233,235U and 239,241Pu. A specific experimental setup has been used at the CERN n_TOF facility for the measurement of the neutron capture cross section of 235U by a set of micromegas fission detectors placed inside a segmented BaF2 Total Absorption Calorimeter.
The experimental area 2 (EAR-2) at CERNs neutron time-of-flight facility (n_TOF), which is operational since 2014, is designed and built as a short-distance complement to the experimental area 1 (EAR-1). The Parallel Plate Avalanche Counter (PPAC) monitor experiment was performed to characterize the beam pro↓le and the shape of the neutron 'ux at EAR-2. The prompt γ-flash which is used for calibrating the time-of-flight at EAR-1 is not seen by PPAC at EAR-2, shedding light on the physical origin of this γ-flash.
Monte Carlo (MC) simulations are an essential tool to determine fundamental features of a neutron beam, such as the neutron flux or the γ-ray background, that sometimes can not be measured or at least not in every position or energy range. Until recently, the most widely used MC codes in this field had been MCNPX and FLUKA. However, the Geant4 toolkit has also become a competitive code for the transport of neutrons after the development of the native Geant4 format for neutron data libraries, G4NDL. In this context, we present the Geant4 simulations of the neutron spallation target of the n_TOF facility at CERN, done with version 10.1.1 of the toolkit. The first goal was the validation of the intra-nuclear cascade models implemented in the code using, as benchmark, the characteristics of the neutron beam measured at the first experimental area (EAR1), especially the neutron flux and energy distribution, and the time distribution of neutrons of equal kinetic energy, the so-called Resolution Function. The second goal was the development of a Monte Carlo tool aimed to provide useful calculations for both the analysis and planning of the upcoming measurements at the new experimental area (EAR2) of the facility.
Aims: Averaged measurements, but not the progression based on multiple assessments of carotid intima-media thickness, (cIMT) are predictive of cardiovascular disease (CVD) events in individuals. Whether this is true for conventional risk factors is unclear.
Methods and results: An individual participant meta-analysis was used to associate the annualised progression of systolic blood pressure, total cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with future cardiovascular disease risk in 13 prospective cohort studies of the PROG-IMT collaboration (n = 34,072). Follow-up data included information on a combined cardiovascular disease endpoint of myocardial infarction, stroke, or vascular death. In secondary analyses, annualised progression was replaced with average. Log hazard ratios per standard deviation difference were pooled across studies by a random effects meta-analysis. In primary analysis, the annualised progression of total cholesterol was marginally related to a higher cardiovascular disease risk (hazard ratio (HR) 1.04, 95% confidence interval (CI) 1.00 to 1.07). The annualised progression of systolic blood pressure, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol was not associated with future cardiovascular disease risk. In secondary analysis, average systolic blood pressure (HR 1.20 95% CI 1.11 to 1.29) and low-density lipoprotein cholesterol (HR 1.09, 95% CI 1.02 to 1.16) were related to a greater, while high-density lipoprotein cholesterol (HR 0.92, 95% CI 0.88 to 0.97) was related to a lower risk of future cardiovascular disease events.
Conclusion: Averaged measurements of systolic blood pressure, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol displayed significant linear relationships with the risk of future cardiovascular disease events. However, there was no clear association between the annualised progression of these conventional risk factors in individuals with the risk of future clinical endpoints.
Destruction of the cosmic γ-ray emitter 26Al in massive stars: study of the key 26Al(n,p) reaction
(2021)
The 26Al(n,p)26Mg reaction is the key reaction impacting on the abundances of the cosmic γ-ray emitter 26Al produced in massive stars and impacts on the potential pollution of the early solar system with 26Al by asymptotic giant branch stars. We performed a measurement of the 26Al(n,p)26Mg cross section at the high-flux beam line EAR-2 at the n_TOF facility (CERN). We report resonance strengths for eleven resonances, nine being measured for the first time, while there is only one previous measurement for the other two. Our resonance strengths are significantly lower than the only previous values available. Our cross-section data range to 150 keV neutron energy, which is sufficient for a reliable determination of astrophysical reactivities up to 0.5 GK stellar temperature.
Aim: Left ventricular non-compaction (LVNC) is perceived as a rare high-risk cardiomyopathy characterized by excess left ventricular (LV) trabeculation. However, there is increasing evidence contesting the clinical significance of LV hyper-trabeculation and the existence of LVNC as a distinct cardiomyopathy. The aim of this study is to assess the association of LV trabeculation extent with cardiovascular morbidity and all-cause mortality in patients undergoing clinical cardiac magnetic resonance (CMR) scans across 57 European centers from the EuroCMR registry.
Methods and Results: We studied 822 randomly selected cases from the EuroCMR registry. Image acquisition was according to international guidelines. We manually segmented images for LV chamber quantification and measurement of LV trabeculation (as per Petersen criteria). We report the association between LV trabeculation extent and important cardiovascular morbidities (stroke, atrial fibrillation, heart failure) and all-cause mortality prospectively recorded over 404 ± 82 days of follow-up. Maximal non-compaction to compaction ratio (NC/C) was mean (standard deviation) 1.81 ± 0.67, from these, 17% were above the threshold for hyper-trabeculation (NC/C > 2.3). LV trabeculation extent was not associated with increased risk of the defined outcomes (morbidities, mortality, LV CMR indices) in the whole cohort, or in sub-analyses of individuals without ischaemic heart disease, or those with NC/C > 2.3.
Conclusion: Among 882 patients undergoing clinical CMR, excess LV trabeculation was not associated with a range of important cardiovascular morbidities or all-cause mortality over ~12 months of prospective follow-up. These findings suggest that LV hyper-trabeculation alone is not an indicator for worse cardiovascular prognosis.
We present measurements of exclusive ensuremathπ+,0 and η production in pp reactions at 1.25GeV and 2.2GeV beam kinetic energy in hadron and dielectron channels. In the case of π+ and π0 , high-statistics invariant-mass and angular distributions are obtained within the HADES acceptance as well as acceptance-corrected distributions, which are compared to a resonance model. The sensitivity of the data to the yield and production angular distribution of Δ (1232) and higher-lying baryon resonances is shown, and an improved parameterization is proposed. The extracted cross-sections are of special interest in the case of pp → pp η , since controversial data exist at 2.0GeV; we find \ensuremathσ=0.142±0.022 mb. Using the dielectron channels, the π0 and η Dalitz decay signals are reconstructed with yields fully consistent with the hadronic channels. The electron invariant masses and acceptance-corrected helicity angle distributions are found in good agreement with model predictions.
Background & Aims: Spontaneous portosystemic shunts (SPSS) frequently develop in liver cirrhosis. Recent data suggested that the presence of a single large SPSS is associated with complications, especially overt hepatic encephalopathy (oHE). However, the presence of >1 SPSS is common. This study evaluates the impact of total cross-sectional SPSS area (TSA) on outcomes in patients with liver cirrhosis.
Methods: In this retrospective international multicentric study, CT scans of 908 cirrhotic patients with SPSS were evaluated for TSA. Clinical and laboratory data were recorded. Each detected SPSS radius was measured and TSA calculated. One-year survival was the primary endpoint and acute decompensation (oHE, variceal bleeding, ascites) was the secondary endpoint.
Results: A total of 301 patients (169 male) were included in the training cohort. Thirty percent of all patients presented with >1 SPSS. A TSA cut-off of 83 mm2 was used to classify patients with small or large TSA (S-/L-TSA). Patients with L-TSA presented with higher model for end-stage liver disease score (11 vs. 14) and more commonly had a history of oHE (12% vs. 21%, p <0.05). During follow-up, patients with L-TSA experienced more oHE episodes (33% vs. 47%, p <0.05) and had lower 1-year survival than those with S-TSA (84% vs. 69%, p <0.001). Multivariate analysis identified L-TSA (hazard ratio 1.66; 95% CI 1.02–2.70, p <0.05) as an independent predictor of mortality. An independent multicentric validation cohort of 607 patients confirmed that patients with L-TSA had lower 1-year survival (77% vs. 64%, p <0.001) and more oHE development (35% vs. 49%, p <0.001) than those with S-TSA.
Conclusion: This study suggests that TSA >83 mm2 increases the risk for oHE and mortality in patients with cirrhosis. Our results support the clinical use of TSA/SPSS for risk stratification and decision-making in the management of patients with cirrhosis.
Lay summary: The prevalence of spontaneous portosystemic shunts (SPSS) is higher in patients with more advanced chronic liver disease. The presence of more than 1 SPSS is common in advanced chronic liver disease and is associated with the development of hepatic encephalopathy. This study shows that total cross-sectional SPSS area (rather than diameter of the single largest SPSS) predicts survival in patients with advanced chronic liver disease. Our results support the clinical use of total cross-sectional SPSS area for risk stratification and decision-making in the management of SPSS.
The SARS-CoV-2 virus is the cause of the respiratory disease COVID-19. As of today, therapeutic interventions in severe COVID-19 cases are still not available as no effective therapeutics have been developed so far. Despite the ongoing development of a number of effective vaccines, therapeutics to fight the disease once it has been contracted will still be required. Promising targets for the development of antiviral agents against SARS-CoV-2 can be found in the viral RNA genome. The 5′- and 3′-genomic ends of the 30 kb SCoV-2 genome are highly conserved among Betacoronaviruses and contain structured RNA elements involved in the translation and replication of the viral genome. The 40 nucleotides (nt) long highly conserved stem-loop 4 (5_SL4) is located within the 5′-untranslated region (5′-UTR) important for viral replication. 5_SL4 features an extended stem structure disrupted by several pyrimidine mismatches and is capped by a pentaloop. Here, we report extensive 1H, 13C, 15N and 31P resonance assignments of 5_SL4 as the basis for in-depth structural and ligand screening studies by solution NMR spectroscopy.
Background and Objectives: Proteins of the coagulation system contribute to autoimmune inflammation in patients with multiple sclerosis (MS). On blood-brain barrier (BBB) disruption, fibrinogen enters the CNS and is rapidly converted to fibrin, unfolding pleiotropic autoimmune mechanisms. Fibrin accumulation leads to subsequent proteolytic degradation that results in D-dimer generation. The primary objective of this study was to determine intrathecal levels of D-dimer in CSF as a measure of intrathecal coagulation cascade activation and to evaluate its diagnostic utility in patients with MS in contrast to healthy subjects. Key secondary objectives included analysis of CSF D-dimer in differential diagnoses of MS and its relation to routine clinical markers of disease activity.
Methods: Patients admitted for the assessment of suspected MS were prospectively recruited from October 2017 to December 2020. Blood plasma and citrated CSF samples were analyzed using a highly sensitive luminescent oxygen channeling immunoassay. Intrathecal generation of D-dimer was analyzed by adjusting for CSF/serum albumin (Qalb) and CSF/plasma D-dimer quotients (QD-dimer), and corresponding CSF fibrinogen levels were determined. Final diagnoses after full evaluation and clinical data were recorded.
Results: Of 187 patients, 113 patients received a diagnosis of MS or clinically/radiologically isolated syndrome. We found increased intrathecal CSF D-dimer generation levels (QD-dimer/Qalb-index) for patients with relapsing-remitting MS (RRMS; n = 71, median 4.7, interquartile range [IQR] 2.5–8.0) when compared with those for disease controls (n = 22, median 2.6, IQR 2.1–4.8, p = 0.031). Absolute CSF D-dimer values correlated with CSF fibrinogen levels (r = 0.463; p < 0 .001) and CSF leukocytes (r = 0.273; p = 0.003) and were elevated in MS patients with contrast enhancement (CE) compared with MS patients without CE on MRI (n = 48, median 6 ng/mL, and IQR 3–15.25 vs n = 41, median 4 ng/mL, and IQR 2–7; p = 0.026). Exploratory subgroup analyses indicated a correlation of intrathecal inflammatory activity and CSF D-dimer levels.
Discussion: D-dimer in CSF can be reliably determined and correlates with markers of CNS inflammation and CSF fibrinogen levels. Adjusted for BBB dysfunction, CSF D-dimer may allow the identification of intrathecal coagulation cascade activation in patients with MS.
Classification of Evidence: This study provides Class I evidence that CSF D-dimer levels are elevated in patients with RRMS.
We study a set of German open-end mutual funds for a time period during which this industry emerged from its infancy. In those years, the distribution channel for mutual funds was dominated by the brick-and-mortar retail networks of the large universal banks. Using monthly observations from 12/1986 through 12/1998, we investigate if cross-sectional return differences across mutual funds affect their market shares. Although such a causal relation has been established in highly competitive markets, such as the United States, the rigid distribution system in place in Germany at the time may have caused retail performance and investment performance to uncouple. In fact, although we observe stark differences in investment performance across mutual funds (and over time), we find no evidence that cross-sectional performance differences affect the market shares of these funds. Klassifikation: G 23
Background Anti-angiogenic treatment is believed to have at least cystostatic effects in highly vascularized tumours like pancreatic cancer. In this study, the treatment effects of the angiogenesis inhibitor Cilengitide and gemcitabine were compared with gemcitabine alone in patients with advanced unresectable pancreatic cancer. Methods A multi-national, open-label, controlled, randomized, parallel-group, phase II pilot study was conducted in 20 centers in 7 countries. Cilengitide was administered at 600 mg/m2 twice weekly for 4 weeks per cycle and gemcitabine at 1000 mg/m2 for 3 weeks followed by a week of rest per cycle. The planned treatment period was 6 four-week cycles. The primary endpoint of the study was overall survival and the secondary endpoints were progression-free survival (PFS), response rate, quality of life (QoL), effects on biological markers of disease (CA 19.9) and angiogenesis (vascular endothelial growth factor and basic fibroblast growth factor), and safety. An ancillary study investigated the pharmacokinetics of both drugs in a subset of patients. Results Eighty-nine patients were randomized. The median overall survival was 6.7 months for Cilengitide and gemcitabine and 7.7 months for gemcitabine alone. The median PFS times were 3.6 months and 3.8 months, respectively. The overall response rates were 17% and 14%, and the tumor growth control rates were 54% and 56%, respectively. Changes in the levels of CA 19.9 went in line with the clinical course of the disease, but no apparent relationships were seen with the biological markers of angiogenesis. QoL and safety evaluations were comparable between treatment groups. Pharmacokinetic studies showed no influence of gemcitabine on the pharmacokinetic parameters of Cilengitide and vice versa. Conclusion There were no clinically important differences observed regarding efficacy, safety and QoL between the groups. The observations lay in the range of other clinical studies in this setting. The combination regimen was well tolerated with no adverse effects on the safety, tolerability and pharmacokinetics of either agent.
Background: The objective of the STREAM Trial was to evaluate the effect of simulation training on process times in acute stroke care.
Methods: The multicenter prospective interventional STREAM Trial was conducted between 10/2017 and 04/2019 at seven tertiary care neurocenters in Germany with a pre- and post-interventional observation phase. We recorded patient characteristics, acute stroke care process times, stroke team composition and simulation experience for consecutive direct-to-center patients receiving intravenous thrombolysis (IVT) and/or endovascular therapy (EVT). The intervention consisted of a composite intervention centered around stroke-specific in situ simulation training. Primary outcome measure was the ‘door-to-needle’ time (DTN) for IVT. Secondary outcome measures included process times of EVT and measures taken to streamline the pre-existing treatment algorithm.
Results: The effect of the STREAM intervention on the process times of all acute stroke operations was neutral. However, secondary analyses showed a DTN reduction of 5 min from 38 min pre-intervention (interquartile range [IQR] 25–43 min) to 33 min (IQR 23–39 min, p = 0.03) post-intervention achieved by simulation-experienced stroke teams. Concerning EVT, we found significantly shorter door-to-groin times in patients who were treated by teams with simulation experience as compared to simulation-naive teams in the post-interventional phase (−21 min, simulation-naive: 95 min, IQR 69–111 vs. simulation-experienced: 74 min, IQR 51–92, p = 0.04).
Conclusion: An intervention combining workflow refinement and simulation-based stroke team training has the potential to improve process times in acute stroke care.